FDA approves Vraylar* for schizophrenia and bipolar disorder: http://finance.yahoo.com/news/allergan-gedeon-richter-plc-receive-183000040.html Forest labs licensed this drug from Hungary’s Gideon Richter many years ago. The FDA issued a CRL on the first review cycle in 2013 (#msg-94290786). *a/k/a cariprazine.